Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login



Statins: the highs and the lows

Negative press seems to follow statins, the most prescribed drugs in England, despite them revolutionising cardiovascular disease prevention.


Statins: the highs and lows

statins prescribing and cost

Figure 1: A decade of dispensing

Source: NHS Digital

Almost 70 million prescription items for statins were dispensed in England in 2017, up from 44 million a decade ago. However, the cost has fallen over the same period from £506m to £316m.

statins benefits vs risks

Figure 2: Benefits versus risks

Source: Lancet 2016;388:2532

Data from two decades of studies show that the benefits of statins outweigh their risks, particularly for those at higher risk of cardiovascular disease.

Statins timeline

Figure 3: Trials and tribulations

From their discovery in 1976, statins have had a rollercoaster ride. Their efficacy in primary and secondary prevention of cardiovascular disease has been proven in numerous studies, but their safety profile has also come under scrutiny, peaking in 2013 when two articles in the BMJ questioned their risk benefit ratio in low-risk individuals, sparking a media storm

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205512

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Pathology and Therapeutics for Pharmacists

    Pathology and Therapeutics for Pharmacists

    An practical, integrated approach to the pathophysiological and pharmacotherapeutic principles underlying the treatment of disease.

    £54.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Statins: the highs and lows
  • statins prescribing and cost
  • statins benefits vs risks
  • Statins timeline
  • scholl infographic full 18

Supplementary information

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.